Medical device recalls Moderate risk

Luminex Corporation recalls VERIGENE Blood Culture Gram-Positive Nucleic Acid Kits (packaged as five-pack carriers) Product Usage: In vitro diagnos…

Recall date
September 14, 2018
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0445-2019
FDA classification
Class II
Brand / firm
Luminex Corporation
Sold / distributed
Worldwide Distribution - US Nationwide in the states of United States - AZ, CA, CO, CT, DC, FL, GA,, IA, ID, IN, KA,, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, ND, NV, NJ, NY, OK,,OH, OR, PA, SC, TN, TX, UT, VT, WA, KS, and VA.. France

Why it was recalled

Potential to lead to a false negative results.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

VERIGENE Blood Culture Gram-Positive Nucleic Acid Kits (packaged as five-pack carriers) Product Usage: In vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria.

Get recall alerts

Free email alert whenever Luminex Corporation has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Luminex Corporation